ACP Living Practice Points: Emerging evidence on antibody response and role in natural immunity
PHILADELPHIA, March 16, 2021 – In new , the »Æ¹ÏµÎµÎapp (ACP) summarizes the current, best available evidence on the antibody response to SARS-CoV-2 infection, including its duration and protection against future re-infection. The new Rapid Living Practice Points, developed by the Scientific Medical Policy Committee of the ACP, What is the Antibody Response and Role in Conferring Natural Immunity Following SARS-CoV-2 Infection?